Drupal.behaviors.print = function(context) {window.print();window.close();}>
Stanford Study Finds miRNA-320a a Broad Regulator of Glycolysis, Potential Drug Target
July 19, 2012
Stanford Study Finds miRNA-320a a Broad Regulator of Glycolysis, Potential Drug Target
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Theradiag Receives $1.6M to Develop Test Kits for HIV/AIDS, Obesity Project
April 9, 2013 / GenomeWeb Daily News
Rosetta Genomics' 2012 Revenues Nearly Double
March 25, 2013 / GenomeWeb Daily News
NIH to Fund Nanoparticle-Based RNAi Cancer Drug Development, miRNA Biomarker Discovery
August 23, 2012 / Gene Silencing News
People in the News: Ron Kalfus, Guy Malchi, Steve Miller
August 23, 2012 / Gene Silencing News
Rosetta Genomics Expects $27.7M in Net Proceeds from Public Offering
July 26, 2012 / GenomeWeb Daily News